Literature DB >> 9506577

Comparative sequence analysis of the human T cell receptor beta chain in juvenile rheumatoid arthritis and juvenile spondylarthropathies: evidence for antigenic selection of T cells in the synovium.

S D Thompson1, K J Murray, A A Grom, M H Passo, E Choi, D N Glass.   

Abstract

OBJECTIVE: To identify features of the T cell receptors (TCRs) present on clonally expanded T cells in the joints of patients with similar types of childhood rheumatic disease. Vbeta8 and Vbeta20 TCRs were selected as prototypic for polyarticular juvenile rheumatoid arthritis (JRA) and pauciarticular/juvenile spondylarthropathy (SpA), respectively.
METHODS: The portion of the TCR beta chain involved in antigen recognition in the synovial tissue, synovial fluid, and peripheral blood from patients with JRA and juvenile SpA was cloned and sequenced. The frequency of expanded clonotypes, size of expansions, the Jbeta region, and sequence motifs were determined for >2,000 sequences.
RESULTS: The majority of Vbeta20 and Vbeta8 clonal expansions were found in the joint rather than the peripheral blood. While instances of both Vbeta8 and Vbeta20 clonal expansion were detected in all disease types, the features of these expanded clonotypes were specific for disease type and Vbeta family. For example, Vbeta20 clonal expansion was characterized by many small expanded clonotypes in samples from patients with pauciarticular JRA and juvenile SpA while single large Vbeta8-specific expansions were found only in patients with polyarticular disease. Motifs specific to individual patients were identified, and for Vbeta20 clonotypes, a motif was found in synovial tissue samples.
CONCLUSION: Identification of common TCR features in oligoclonal expansions within individual patients and between patients with the same type of JRA suggests the recognition of a common or limited group of antigens in these diseases.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9506577     DOI: 10.1002/1529-0131(199803)41:3<482::AID-ART15>3.0.CO;2-G

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  8 in total

Review 1.  Type 1 and type 2 immune responses in children: their relevance in juvenile arthritis.

Authors:  L R Wedderburn; P Woo
Journal:  Springer Semin Immunopathol       Date:  1999

2.  TCR Vβ repertoire in an Italian longeval population including centenarians.

Authors:  G Pennesi; M Morellini; P Lulli; S Cappellacci; G Brioli; C Franceschi; S Trabace
Journal:  J Am Aging Assoc       Date:  2001-04

3.  T cell receptor variable β20-1 harbors a nucleotide binding pocket in the CDR2β loop.

Authors:  Stephan Watkins; Werner J Pichler
Journal:  Open J Immunol       Date:  2013-09

4.  Altered expression of the TCR signaling related genes CD3 and FcεRIγ in patients with aplastic anemia.

Authors:  Bo Li; Sichu Liu; Yuzhe Niu; Su Fang; Xiuli Wu; Zhi Yu; Shaohua Chen; Lijian Yang; Yangqiu Li
Journal:  J Hematol Oncol       Date:  2012-03-08       Impact factor: 17.388

5.  T-cell activation without proliferation in juvenile idiopathic arthritis.

Authors:  Antony P B Black; Hansha Bhayani; Clive A J Ryder; Janet M M Gardner-Medwin; Taunton R Southwood
Journal:  Arthritis Res       Date:  2001-11-21

6.  Correlation of low CD73 expression on synovial lymphocytes with reduced adenosine generation and higher disease severity in juvenile idiopathic arthritis.

Authors:  Sophie Botta Gordon-Smith; Simona Ursu; Simon Eaton; Halima Moncrieffe; Lucy R Wedderburn
Journal:  Arthritis Rheumatol       Date:  2015-02       Impact factor: 10.995

7.  Complex genetic predisposition in adult and juvenile rheumatoid arthritis.

Authors:  Bianca Miterski; Susanne Drynda; Gundula Böschow; Wolfram Klein; Joachim Oppermann; Jörn Kekow; Jörg Thomas Epplen
Journal:  BMC Genet       Date:  2004-02-04       Impact factor: 2.797

8.  CXCR3/CXCL10 expression in the synovium of children with juvenile idiopathic arthritis.

Authors:  Georgia Martini; Francesco Zulian; Fiorella Calabrese; Marta Bortoli; Monica Facco; Anna Cabrelle; Marialuisa Valente; Franco Zacchello; Carlo Agostini
Journal:  Arthritis Res Ther       Date:  2005-01-07       Impact factor: 5.156

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.